smoker
[용어속성] Term
COVID-19 Disease Course in Former Smokers, Smokers and COPD Patients
Physiology
[키워드] acute respiratory syndrome
caused
chronic obstructive
chronic obstructive pulmonary disease
Comorbidities
Comorbidity
COPD
coronavirus
Course
COVID-19
COVID-19 pandemic
COVID-19 patient
demonstrated
Diabetes Mellitus
disease
disease severity
former
group
Health
higher risk
Hospital admission
hospital discharge
Hospitalization
implication
increase in
Infection
Inflammatory marker
no difference
obesity
Older age
Other
pandemic
Patient
patients
patients with COVID-19
performed
populations
pulmonary disease
Respiratory disease
risk factor
SARS-CoV-2
severe COVID-19
smoker
Smokers
smoking
systemic arterial hypertension
the disease
[DOI] 10.3389/fphys.2020.637627 PMC 바로가기 [Article Type] Physiology
[DOI] 10.3389/fphys.2020.637627 PMC 바로가기 [Article Type] Physiology
First Report on Smoking and Infection Control Behaviours at Outdoor Hotspots during the COVID-19 Pandemic: An Unobtrusive Observational Study
Observational Study
[키워드] age
carried
conducted
Control
COVID-19
COVID-19 pandemic
eight
Face mask
Hong Kong
hotspot
infection control
infection control behaviours
nine
observation
observé
outbreak
practised hand hygiene
report
risk of infection
smoker
Smokers
smoking
Volume
while
[DOI] 10.3390/ijerph18031031 PMC 바로가기 [Article Type] Observational Study
[DOI] 10.3390/ijerph18031031 PMC 바로가기 [Article Type] Observational Study
Quit Experiences among Primary Care Patients Enrolled in a Smoking Cessation Pilot RCT Early in the COVID-19 Pandemic
Randomized Controlled Trial
[키워드] age
analyzed
benefit
boredom
change
COVID-19
COVID-19 complication
COVID-19 pandemic
Effects
enrolled
experience
finding
groups
increased risk
individual
Intervention
interview
Isolation
medication
Nicotine
Older
participant
Patient
primary care
RCT
reaction
reported
representing
risk
risk perceptions
smoker
smoking
smoking cessation
Stress
tobacco use
Trial
trial participant
while
[DOI] 10.3390/ijerph18031011 PMC 바로가기 [Article Type] Randomized Controlled Trial
[DOI] 10.3390/ijerph18031011 PMC 바로가기 [Article Type] Randomized Controlled Trial
Smoking prevalence among hospitalized COVID-19 patients and its association with disease severity and mortality: an expanded re-analysis of a recent publication
Research
[키워드] 95%CI
agonist
Analysis
analyzed
association
associations
calculated
China
COVID-19
COVID-19 severity
develop
disease severity
Effect
examined
expand
expected
Gender
Health
heterogeneous
Hospitalization
hospitalized COVID-19 patient
hospitalized COVID-19 patients
hospitalized patients
Hypothesis
Meta-analysis
Mortality
Odds ratio
Patient
populations
POR
Prevalence
proportion
random-effect
Random-effects meta-analysis
Result
severe COVID-19
smoker
Smokers
smoking
statistically significant
therapeutic options
USA
were used
[DOI] 10.1186/s12954-020-00437-5 PMC 바로가기 [Article Type] Research
[DOI] 10.1186/s12954-020-00437-5 PMC 바로가기 [Article Type] Research
The Perceived Impact of COVID-19 among Treatment-Seeking Smokers: A Mixed Methods Approach
Article
[키워드] activities
benefit
change
changed
changes in
collected
consequence
coronavirus
COVID-19
COVID-19 pandemic
enrolled
explain
Health
help
Impact
indicated
New York
pandemic
participant
Perceived
Philadelphia
public health
qualitative data
Quantitative data
questionnaire
reported
resulting
severity of COVID-19
smoker
Smokers
smoking
smoking cessation
Stress
Support
Theory of Planned Behavior
These data
tobacco use
Trial
triggers
[DOI] 10.3390/ijerph18020505 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/ijerph18020505 PMC 바로가기 [Article Type] Article
Can spontaneous pneumothorax be resolved in COVID-19 without hospital care? A case report
Case Report
[키워드] Can
Case report
clinical experience
Complication
coronavirus disease
COVID-19
COVID-19 case
CT scan
Diagnosis
Diagnostic method
dry cough
Follow-up
general condition
hemodynamic stability
hospital
Hospitalization
Infection
Intervention
invasive
Iran
Lungs
male
medical intervention
Novel coronavirus infection
pandemic
Pneumothorax
protocols
quarantine
radiology
reduce
resolved
smoker
Spread
suggested
suspicious patients
Treatment
with COVID-19
Wuhan, China
[DOI] 10.22088/cjim.12.0.368 PMC 바로가기 [Article Type] Case Report
[DOI] 10.22088/cjim.12.0.368 PMC 바로가기 [Article Type] Case Report
Perceived risk, attitudes, and behavior of cigarette smokers and nicotine vapers receiving buprenorphine treatment for opioid use disorder during the COVID-19 pandemic
Research article
[키워드] AOR
asked
Boston
Buprenorphine
cigarette smoking
Community
complications
conducted
COVID-19
COVID-19 pandemic
disorder
E-cigarettes
Electronic cigarettes
FIVE
Health
individual
Infection
Most patient
Opioid use disorder
pandemic
participant
Patient
Perceived
Perceived risk
Population
Prevalence
question
receiving
reported
Result
risk
risk of COVID-19
smoker
smoking
Treatment
urgency
vaping
[DOI] 10.1016/j.drugalcdep.2020.108438 [Article Type] Research article
[DOI] 10.1016/j.drugalcdep.2020.108438 [Article Type] Research article
Biological agents for rheumatic diseases in the outbreak of COVID-19: friend or foe?
COVID-19 발생 시 류마티스 질환에 대한 생물학적 제제: 친구 또는 적?
Observational Study
[키워드] affected
age
analysed
Autoimmunity
Baricitinib
Biological agent
biological therapy
cardiovascular disease
Care
Community
Comorbidities
covariate
COVID-19
COVID-19 infection
cytokine production
determine
diagnosed
diagnosed with COVID-19
Diagnosis
disease
dose
drug
Epidemiology
exacerbated
form
General population
glucocorticoid
group
hospital
Hospital admission
hospitalisation
hypertension
IL-1
IL-6
IL-6 inhibitor
IL-6 inhibitors
immunosuppressed patient
incidence of COVID-19
incidence rate
Inflammation
Inflammatory
inhibitor
inhibitors
intensive care
IQR
JAK inhibitor
less
lowest
management
manifestation
median age
multivariate logistic regression
no difference
no significant difference
occur
Older
outbreak
outpatient clinic
Patient
patients
patients died
patients treated
patients with COVID-19
performed
positive
prognosis of patient
proportions
Protective
protective effect
protective factor
raised
receiving
required
retrospective
rheumatic disease
Rheumatic diseases
rheumatological
rheumatology
risk
risk factor
sarilumab
SARS-CoV-2
severe COVID-19 disease
Sex
smoker
Spain
suggested
tested
therapy
Tocilizumab
Treatment
with COVID-19
[DOI] 10.1136/rmdopen-2020-001439 PMC 바로가기 [Article Type] Observational Study
[DOI] 10.1136/rmdopen-2020-001439 PMC 바로가기 [Article Type] Observational Study
Nicotinic cholinergic system and COVID-19: In silico evaluation of nicotinic acetylcholine receptor agonists as potential therapeutic interventions
Regular Article
[키워드] Abstract
Acetylcholine
Acetylcholine-binding protein
ACh, Acetylcholine
AChAcetylcholine
AChBP, Acetylcholine-binding protein
AChBPAcetylcholine-binding protein
acute respiratory distress syndrome
agonist
agonists
Anti-inflammatory
approved
ARDS, acute respiratory distress syndrome
ARDSacute respiratory distress syndrome
Basic Local Alignment Search Tool
binding
BLAST, Basic Local Alignment Search Tool
BLASTBasic Local Alignment Search Tool
Central nervous system
CHARMM, Chemistry at Harvard Macromolecular Mechanics
CHARMMChemistry at Harvard Macromolecular Mechanics
Chemistry at Harvard Macromolecular Mechanics
cholinergic
Cholinergic agonists
clinical manifestation
CNS, Central Nervous System
CNSCentral Nervous System
complexes
condition
constant number
coronavirus
CoV, coronavirus
CoVcoronavirus
COVID-19
DCD, single precision binary FORTRAN
DCDsingle precision binary FORTRAN
disorder
dysregulation
ECD, extracellular domain
ECDextracellular domain
energy
epitope
extracellular domain
glycoprotein
HADDOCK, High Ambiguity Driven protein-protein DOCKing
HADDOCKHigh Ambiguity Driven protein-protein DOCKing
High Ambiguity Driven protein-protein DOCKing
High-mobility group protein 1
HMGB1, High-mobility group protein 1
HMGB1High-mobility group protein 1
homologous
hospitalized COVID-19 patients
Hypothesis
IL, interleukin
ILInterleukin
in vitro
in vivo
Inflammatory
Interaction
interleukin
Jak2, Janus kinases 2
Jak2Janus kinases 2
Janus kinases 2
LBD, Ligand Binding Domain
LBDLigand Binding Domain
lig, ligand
Ligand
Ligand Binding Domain
ligligand
MD, molecular dynamics
MDMolecular Dynamics
MDS, Molecular Dynamics Simulations
MDSMolecular Dynamics Simulations
MERS, Middle East respiratory syndrome
MERSMiddle East Respiratory Syndrome
Middle East respiratory syndrome
molecular dynamics
molecular dynamics simulations
nAChRs, nicotinic acetylcholine receptors
nAChRsnicotinic acetylcholine receptors
NAMD, Nanoscale Molecular Dynamics
NAMDNanoscale Molecular Dynamics
Nanoscale Molecular Dynamics
National Center for Biotechnology Information
NCBI, National Center for Biotechnology Information
NCBINational Center for Biotechnology Information
NCS, Nicotinic Cholinergic System
NCSNicotinic Cholinergic System
neurological
NF-kB, nuclear factor kappa-light-chain-enhancer of activated B cells
NF-kBnuclear factor kappa-light-chain-enhancer of activated B cells
Nicotinic acetylcholine receptors
Nicotinic Cholinergic System
NPT, constant number, pressure, energy
NPTconstant number
nuclear factor kappa-light-chain-enhancer of activated B cells
NVT, constant number, volume, energy
NVTconstant number
pandemic
Particle Mesh Ewald
patients with COVID-19
PDB, Protein Data Bank
PDBProtein Data Bank
PME, Particle Mesh Ewald
PMEParticle Mesh Ewald
pressure
Prevalence
Prevent
PRODIGY, PROtein binDIng enerGY prediction
PRODIGYPROtein binDIng enerGY prediction
PROtein binDIng enerGY prediction
Protein Data Bank
PyMOL, Python Molecule
PyMOLPython Molecule
Python Molecule
RBD, receptor binding domain
RBDReceptor Binding Domain
receptor
Receptor binding domain
RMSD, Root-mean-square deviation
RMSDRoot-mean-square deviation
Root-mean-square deviation
SARS - 2 Spike Subunit 1 protein
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 S1
SARS-CoV-2 S1, SARS - 2 Spike Subunit 1 protein
SARS-CoV-2 S1SARS - 2 Spike Subunit 1 protein
SARS, Severe acute respiratory syndrome
SARSSevere Acute Respiratory Syndrome
Saturation Transfer Difference Nuclear Magnetic Resonance
Scientific community
Severe acute respiratory syndrome
severe COVID-19
severe symptoms
signal transducer and activator of transcription 3
significantly
single precision binary FORTRAN
smoker
smoking
spike
spike glycoprotein
STAT3, signal transducer and activator of transcription 3
STAT3signal transducer and activator of transcription 3
STD NMR, Saturation Transfer Difference Nuclear Magnetic Resonance
STD NMRSaturation Transfer Difference Nuclear Magnetic Resonance
substrate
Symptom
System
the SARS-CoV-2
Therapeutic approach
therapeutic intervention
therapeutic option
TNF, Tumor Necrosis Factor
TNFTumor Necrosis Factor
toxins
triggering
tumor necrosis factor
Visual Molecular Dynamics
VMD, Visual Molecular Dynamics
VMDVisual Molecular Dynamics
Volume
[DOI] 10.1016/j.toxrep.2020.12.013 PMC 바로가기 [Article Type] Regular Article
[DOI] 10.1016/j.toxrep.2020.12.013 PMC 바로가기 [Article Type] Regular Article